Vraylar (Allergan USA, Inc.)
Welcome to the PulseAid listing for the Vraylar drug offered from Allergan USA, Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan USA, Inc. |
| NON-PROPRIETARY NAME: | cariprazine |
| SUBSTANCE NAME: | CARIPRAZINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-09-17 |
| END MARKETING DATE: | 0000-00-00 |
Vraylar HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vraylar from Allergan USA, Inc. |
| LABELER NAME: | Allergan USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/1) |
| START MARKETING DATE: | 2015-09-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61874-115_73968081-834a-4d3c-8054-a37179cfe047 |
| PRODUCT NDC: | 61874-115 |
| APPLICATION NUMBER: | NDA204370 |
Other CARIPRAZINE Pharmaceutical Manufacturers / Labelers:
